Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (2): 208-215    DOI: 10.12891/ceog3381.2017
Original Research Previous articles | Next articles
Obstetric and neonatal outcomes in women aged 40 years or older after in vitro fertilization
S. Rakic1, *(), N. Zecevic1, S. Jankovic-Raznatovic1, M. Vasiljevic1, R. Anicic1
1 Medical Faculty University of Belgrade, University Hospital of Gynecology and Obstetrics Narodni Front, Belgrade, Serbia
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: The aim of this study was to determine the rate of complications in pregnancy and during delivery, as well as neonatal outcomes, in women who underwent in vitro fertilization (IVF) and who are 40 years of age or older. Materials and Methods: This was a prospective study. The study group consisted of 29 women who underwent IVF. The control group consisted of 32 women who had a spontaneous pregnancy. Results: Pregnancy complications occurred in 86.21% of women in the study group, and in 46.87% of women in the control group. The proportion of cesarean sections (CS) was 84.62% in the study group, and 21.87% in the control group. Birth weight < 1,500 grams and < 2,500 grams was present in 17.16% and 22.86% of newborns in the study group, respectively. In the control group, birth weight < 1,500 grams and < 2,500 grams was present in 5.55% and 8.33% of newborns, respectively. Neonatal intensive care unit admissions included 22.86% newborns from the study group and 8.33% from the control group. Conclusion: Pregnancy, delivery, and neonatal complications were more frequent in the study (IVF) group.
Key words:  In vitro fertilization      Pregnancy      Delivery      Newborn     
Published:  10 April 2017     
*Corresponding Author(s):  S. RAKIC     E-mail:  sneskarakic@gmail.com

Cite this article: 

S. Rakic, N. Zecevic, S. Jankovic-Raznatovic, M. Vasiljevic, R. Anicic. Obstetric and neonatal outcomes in women aged 40 years or older after in vitro fertilization. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 208-215.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3381.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I2/208

[1] S. Srisukho, K. Srisupundit, T. Tongsong. Fulfillment of the criteria for diagnosis of cephalo-pelvic disproportion: ACOG guidelines[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 500-504.
[2] N. Dropińska, K. Chmaj-Wierzchowska, M. Wojciechowska, M. Wilczak. What is the state of knowledge on preterm birth?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 505-510.
[3] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[4] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[5] G. Sel, A. Barut, Ü. Özmen, A. Y. Akdemir, S. Harma, B. Aynalı, M. Harma, M.İ. Harma. Mode of delivery does not have a relationship with high-risk HPV positivity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 541-545.
[6] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[7] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[8] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[9] Z.Y. Chang, R. Cao, R.C. Xu, Y. Cheng, Q.J. Wan. Pregnancy in a peritoneal dialysis patient undergoing intermittent peritoneal dialysis during the third trimester of pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 596-599.
[10] C.Y. Huang, T.C. Chao, H.C. Chien, Y.L. Liu. Outcome of shared decision-making in a patient with primary herpes gingivostomatitis during pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 604-606.
[11] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[12] K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku. Anti-E alloimmunization in a pregnancy with a low antibody titer[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 614-616.
[13] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[14] G. Keren, G. Ayala. Factors associated with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 391-395.
[15] H. Cokmez, C. Bayram. Pituitary apoplexy developing during pregnancy: escape from the verge of death[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 429-431.
No Suggested Reading articles found!